At a glance
ClinicalIndex Comparison RecordN/ACompleted· 18 enrolled
Drug / intervention
Point of care device to measure HbA1cother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Enhancing Cardiovascular Health Equity in Mothers and Children Through Home Visiting
In Brief
An observational study evaluating Point of care device to measure HbA1c for Pregnant and Postpartum. Completed, enrolled 18 participants across 1 site.
Detailed Summary
Conduct a pilot study to test feasibility of doing remote data collection with a point of care device that measures HbA1c.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPregnant, Postpartum
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
First PostedFeb 2023
Enrollment StartFeb 2023
Primary CompletionApr 2024
TodayJul 2026
First PostedFeb 13, 2023
Enrollment StartFeb 24, 2023
Primary CompletionApr 25, 2024
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 3.4 years ago
Interventions
Point of care device to measure HbA1cother
After consent the participant will meet with the research team virtually to obtain HbA1c. The HbA1c self check equipment will be sent to the participant. During the video call the research team will talk the participant through obtaining their HbA1c with the point of care device.